SCHEMBL9699295

SCHEMBL9699295

O=C(Oc1ccc(S(=O)(=O)c2ccc(CBr)cc2)cc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
PARP10 Q53GL7 1/20 0.49
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
KMT2A Q03164 8/20 0.47
ALDH1A1 P00352 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
PKM P14618 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 3/20 0.46
POLB P06746 1/20 0.45
RAB9A P51151 1/20 0.44
ELANE P08246 1/20 0.42
PRMT1 Q99873 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7616356 0.89 CES2 (0.59) MAPTSMN1; SMN2PARP10CES2CES1
SCHEMBL11775909 0.88 PARP10 (0.61) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL8983809 0.83 CES2 (0.59) MAPTSMN1; SMN2PARP10CES2CES1
SCHEMBL9806487 0.82 ELANE (0.58) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL9806485 0.82 PARP10 (0.54) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL14725833 0.81 MAPT (0.69) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL12123501 0.81 MAPT (0.72) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL9528723 0.81 SMN1; SMN2 (0.61) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL26039005 0.79 SMN1; SMN2 (0.59) MAPTSMN1; SMN2PARP10KMT2AALDH1A1
SCHEMBL12199954 0.79 MAPT (0.55) MAPTSMN1; SMN2KMT2AALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992005173-A1 SUBSTITUTED TRICYCLIC COMPOUNDS AGOURON PHARMACEUTICALS, INC. (US) 1992-04-02 WO disclosed